Abstract
The HINT1 protein, a member of the histidine triad (HIT) family, is highly conserved in diverse species and ubiquitously expressed in mammalian tissues. However, its precise function in mammalian cells is not known. As a result of its structural similarity to the tumor-suppressor protein FHIT, we used homozygous-deleted Hint1 mice to study its role in tumorigenesis. We discovered that after 2 to 3 years of age the spontaneous tumor incidence in Hint1 −/− mice was significantly greater than that in wild-type Hint1 +/+ mice (P<0.05). Using a well-established mouse model of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis we found a marked and significant (P<0.05) increase in the incidence of mammary and ovarian tumors in both, Hint1 −/− and +/− mice versus +/+ mice. The Hint1 −/− and +/− mice had similar tumor incidence and similar tumor histologies. Therefore, deletion of Hint1 in mice enhances both spontaneous tumor development and susceptibility to tumor induction by DMBA. In addition, since the Hint1 +/− tumors retained expression of the unmutated wild-type allele, Hint1 is haplo-insufficient with respect to tumor suppression in this model system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aldaz CM, Liao QY, LaBate M, Johnston DA . (1996). Carcinogenesis 17: 2069–2072.
Archuleta MM, Born JL, Montano RM, Burchiel SW . (1992). Toxicol Appl Pharmacol 113: 133–137.
Barnes LD, Garrison PN, Siprashvili Z, Guranowski A, Robinson AK, Ingram SW et al. (1996). Biochemistry 35: 11529–11535.
Bieganowski P, Garrison PN, Hodawadekar SC, Faye G, Barnes LD, Brenner C . (2002). J Biol Chem 277: 10852–10860.
Brenner C . (2002). Biochemistry 41: 9003–9014.
Brenner C, Garrison P, Gilmour J, Peisach D, Ringe D, Petsko GA et al. (1997). Nat Struct Biol 4: 231–238.
Brzoska PM, Chen H, Levin NA, Kuo WL, Collins C, Fu KK et al. (1996). Genomics 36: 151–156.
Brzoska PM, Chen H, Zhu Y, Levin NA, Disatnik MH, Mochly-Rosen D et al. (1995). Proc Natl Acad Sci USA 92: 7824–7828.
Buters J, Quintanilla-Martinez L, Schober W, Soballa VJ, Hintermair J, Wolff T et al. (2003). Carcinogenesis 24: 327–334.
Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ et al. (2000). Oncogene 19: 968–988.
Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ . (1998). Nature 396: 177–180.
Fong LY, Fidanza V, Zanesi N, Lock LF, Siracusa LD, Mancini R et al. (2000). Proc Natl Acad Sci USA 97: 4742–4747.
Gilmour J, Liang N, Lowenstein JM . (1997). Biochem J 326: 471–477.
Goerlich O, Foeckler R, Holler E . (1982). Eur J Biochem 126: 135–142.
Guranowski A . (2004). Front Biosci 9: 1398–1411.
Guranowski A, Starzynska E, Taylor GE, Blackburn GM . (1989). Biochem J 262: 241–244.
Huebner K, Garrison PN, Barnes LD, Croce CM . (1998). Annu Rev Genet 32: 7–31.
Ingvarsson S . (2001). Semin Cancer Biol 11: 361–366.
Inoue K, Zindy F, Randle DH, Rehg JE, Sherr CJ . (2001). Genes Dev 15: 2934–2939.
Jackson RJ, Engelman RW, Coppola D, Cantor AB, Wharton W, Pledger WJ . (2003). Cancer Res 63: 3021–3025.
Kisselev LL, Justesen J, Wolfson AD, Frolova LY . (1998). FEBS Lett 427: 157–163.
Klein MG, Yao Y, Slosberg ED, Lima CD, Doki Y, Weinstein IB . (1998). Exp Cell Res 244: 26–32.
Knudson Jr AG . (1971). Proc Natl Acad Sci USA 68: 820–823.
Korsisaari N, Makela TP . (2000). J Biol Chem 275: 34837–34840.
Korsisaari N, Rossi DJ, Luukko K, Huebner K, Henkemeyer M, Makela TP . (2003). Mol Cell Biol 23: 3929–3935.
Lee YN, Nechushtan H, Figov N, Razin E . (2004). Immunity 20: 145–151.
Lima CD, Klein MG, Hendrickson WA . (1997). Science 278: 286–290.
Lima CD, Klein MG, Weinstein IB, Hendrickson WA . (1996). Proc Natl Acad Sci USA 93: 5357–5362.
Malkinson AM, Thaete LG . (1986). Cancer Res 46: 1694–1697.
Medina D, Butel JS, Socher SH, Miller FL . (1980). Cancer Res 40: 368–373.
Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J et al. (1996). Cell 84: 587–597.
Pierce Jr DF, Gorska AE, Chytil A, Meise KS, Page DL, Coffey Jr RJ et al. (1995). Proc Natl Acad Sci USA 92: 4254–4258.
Qing WG, Conti CJ, LaBate M, Johnston D, Slaga TJ, MacLeod MC . (1997). Carcinogenesis 18: 553–559.
Quon KC, Berns A . (2001). Genes Dev 15: 2917–2921.
Razin E, Zhang ZC, Nechushtan H, Frenkel S, Lee YN, Arudchandran R et al. (1999). J Biol Chem 274: 34272–34276.
Seraphin B . (1992). DNA Seq 3: 177–179.
Su T, Suzui M, Wang L, Lin CS, Xing WQ, Weinstein IB . (2003). Proc Natl Acad Sci USA 100: 7824–7829.
Threadgill DW, Yee D, Matin A, Nadeau JH, Magnuson T . (1997). Mamm Genome 8: 390–393.
Vartanian A, Alexandrov I, Prudowski I, McLennan A, Kisselev L . (1999). FEBS Lett 456: 175–180.
Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D et al. (1998). Embo J 17: 4657–4667.
Witty JP, Lempka T, Coffey Jr RJ, Matrisian LM . (1995). Cancer Res 55: 1401–1406.
Yao Y, Slosberg ED, Wang L, Hibshoosh H, Zhang YJ, Xing WQ et al. (1999). Oncogene 18: 5159–5166.
Yuan BZ, Jefferson AM, Popescu NC, Reynolds SH . (2004). Neoplasia 6: 412–419.
Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, Valtieri M et al. (2001). Proc Natl Acad Sci USA 98: 10250–10255.
Acknowledgements
We thank MM Mansukhani and H Hibshoosh, Department of Pathology, Columbia University, for valuable advice on the histological studies, and CW Rumsey and A Herron, Institute of Comparative Medicine, Columbia University, for histopathological verification. We are also grateful to members of the Weinstein laboratory for critical comments on the manuscript. This research was supported by National Cancer Institute Grant CA26056-24, the TJ Martell Foundation, and the National Foundation for Cancer Research (to IB Weinstein), and National Cancer Institute Grants ES05116 and P30ES09089 (to RM Santella).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, H., Zhang, Y., Su, T. et al. Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene 25, 713–721 (2006). https://doi.org/10.1038/sj.onc.1209111
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209111
Keywords
This article is cited by
-
Human HINT1 Mutant Proteins that Cause Axonal Motor Neuropathy Exhibit Anomalous Interactions with Partner Proteins
Molecular Neurobiology (2021)
-
Deacetylation by SIRT1 promotes the tumor-suppressive activity of HINT1 by enhancing its binding capacity for β-catenin or MITF in colon cancer and melanoma cells
Experimental & Molecular Medicine (2020)
-
The role of HINT1 in methamphetamine-induced behavioral sensitization
Psychopharmacology (2020)
-
Second messenger Ap4A polymerizes target protein HINT1 to transduce signals in FcεRI-activated mast cells
Nature Communications (2019)
-
Overexpression of Zm-HINT1 Confers Salt and Drought Tolerance in Arabidopsis thaliana
Plant Molecular Biology Reporter (2018)